S-adenosylmethionine limitation induces p38 mitogen-activated protein kinase and triggers cell cycle arrest in G1

Journal of Cell Science

Volumn 127, Issue 1, 2014, Pages 50-59

  Lin, Da Wei ^a   Chung, Benjamin P ^a   Kaiser, Peter ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell cycle; Mapkapk2; Mk2; One carbon cycle; P38 MAPK; S adenosylmethionine; Sam

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN E; METHIONINE ADENOSYLTRANSFERASE; METHYL GROUP; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; S ADENOSYLMETHIONINE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; G1 PHASE CELL CYCLE CHECKPOINT; GENETIC MANIPULATION; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CELL CYCLE; MAPKAPK2; MK2; ONE CARBON CYCLE; P38 MAPK; S-ADENOSYLMETHIONINE; SAM;

B-LYMPHOCYTES; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; DNA METHYLATION; EPIGENESIS, GENETIC; G1 PHASE; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; METHIONINE; METHIONINE ADENOSYLTRANSFERASE; MITOGEN-ACTIVATED PROTEIN KINASE 14; MULTIPROTEIN COMPLEXES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; S-ADENOSYLMETHIONINE; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84891439517     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.127811     Document Type: Article

References (55)

1. Attia, R. R., Gardner, L. A., Mahrous, E., Taxman, D. J., Legros, L., Rowe, S., Ting, J. P., Geller, A. and Kotb, M. (2008). Selective targeting of leukemic cell growth in vivo and in vitro using a gene silencing approach to diminish Sadenosylmethionine synthesis. J. Biol. Chem. 283, 30788-30795.
2. Bartek, J. and Lukas, J. (2003). Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3, 421-429.
3. Booher, K., Lin, D. W., Borrego, S. L. and Kaiser, P. (2012). Downregulation of Cdc6 and pre-replication complexes in response to methionine stress in breast cancer cells. Cell Cycle 11, 4414-4423.
4. Casero, R. A., Jr and Marton, L. J. (2007). Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat. Rev. Drug Discov. 6, 373-390.
5. de Thé, H. and Chen, Z. (2010). Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat. Rev. Cancer 10, 775-783.
6. Easton, J. B., Kurmasheva, R. T. and Houghton, P. J. (2006). IRS-1: auditing the effectiveness of mTOR inhibitors. Cancer Cell 9, 153-155.
7. Edinger, A. L. and Thompson, C. B. (2002). Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol. Biol. Cell 13, 2276-2288.
8. Guo, H., Lishko, V. K., Herrera, H., Groce, A., Kubota, T. and Hoffman, R. M. (1993). Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo. Cancer Res. 53, 5676-5679.
9. Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E. and Shaw, R. J. (2008). AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214-226.
10. Halpern, B. C., Clark, B. R., Hardy, D. N., Halpern, R. M. and Smith, R. A. (1974). The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture. Proc. Natl. Acad. Sci. USA 71, 1133-1136.
11. Hanahan, D. and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
12. Hardie, D. G., Ross, F. A. and Hawley, S. A. (2012). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251-262.
13. Hartwell, L. H. and Weinert, T. A. (1989). Checkpoints: controls that ensure the order of cell cycle events. Science 246, 629-634.
14. Hassepass, I., Voit, R. and Hoffmann, I. (2003). Phosphorylation at serine 75 is required for UV-mediated degradation of human Cdc25A phosphatase at the Sphase checkpoint. J. Biol. Chem. 278, 29824-29829.
15. Hayakawa, T., Kobayashi, Y., Cui, X. and Hirano, S. (2005). A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch. Toxicol. 79, 183-191.
16. Holley, R. W. and Kiernan, J. A. (1974). Control of the initiation of DNA synthesis in 3T3 cells: low-molecular weight nutrients. Proc. Natl. Acad. Sci. USA 71, 2942-2945.
17. Jani, T. S., Gobejishvili, L., Hote, P. T., Barve, A. S., Joshi-Barve, S., Kharebava, G., Suttles, J., Chen, T., McClain, C. J. and Barve, S. (2009). Inhibition of methionine adenosyltransferase II induces FasL expression, Fas-DISC formation and caspase-8-dependent apoptotic death in T leukemic cells. Cell Res. 19, 358-369.
18. Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J. and Thompson, C. B. (2005). AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 18, 283-293.
19. Kaiser, P., Su, N.-Y., Yen, J. L., Ouni, I. and Flick, K. (2006). The yeast ubiquitin ligase SCFMet30: connecting environmental and intracellular conditions to cell division. Cell Div. 1, 16.
20. Khaled, A. R., Bulavin, D. V., Kittipatarin, C., Li, W. Q., Alvarez, M., Kim, K., Young, H. A., Fornace, A. J. and Durum, S. K. (2005). Cytokine-driven cell cycling is mediated through Cdc25A. J. Cell Biol. 169, 755-763.
21. Kim, J. Y., Choi, J. A., Kim, T. H., Yoo, Y. D., Kim, J. I., Lee, Y. J., Yoo, S. Y., Cho, C. K., Lee, Y. S. and Lee, S. J. (2002). Involvement of p38 mitogenactivated protein kinase in the cell growth inhibition by sodium arsenite. J. Cell. Physiol. 190, 29-37.
22. Kitchin, K. T. and Conolly, R. (2010). Arsenic-induced carcinogenesis-oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment. Chem. Res. Toxicol. 23, 327-335.
23. Koomoa, D. L., Yco, L. P., Borsics, T., Wallick, C. J. and Bachmann, A. S. (2008). Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma. Cancer Res. 68, 9825-9831.
24. Koomoa, D. L., Borsics, T., Feith, D. J., Coleman, C. C., Wallick, C. J., Gamper, I., Pegg, A. E. and Bachmann, A. S. (2009). Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma. Mol. Cancer Ther. 8, 2067-2075.
25. Kreis, W. (1979). Tumor therapy by deprivation of L-methionine: rationale and results. Cancer Treat. Rep. 63, 1069-1072.
26. Laplante, M. and Sabatini, D. M. (2012). mTOR signaling in growth control and disease. Cell 149, 274-293.
27. Li, S., Ilaria, R. L., Jr, Million, R. P., Daley, G. Q. and Van Etten, R. A. (1999). The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J. Exp. Med. 189, 1399-1412.
28. Liang, J., Shao, S. H., Xu, Z. X., Hennessy, B., Ding, Z., Larrea, M., Kondo, S., Dumont, D. J., Gutterman, J. U., Walker, C. L. et al. (2007). The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat. Cell Biol. 9, 218-224.
29. Loenen, W. A. (2006). S-adenosylmethionine: jack of all trades and master of everything? Biochem. Soc. Trans. 34, 330-333.
30. Lombardini, J. B. and Talalay, P. (1970). Formation, functions and regulatory importance of S-adenosyl-L-methionine. Adv. Enzyme Regul. 9, 349-384.
31. Lu, S. and Epner, D. E. (2000). Molecular mechanisms of cell cycle block by methionine restriction in human prostate cancer cells. Nutr. Cancer 38, 123-130.
32. Mailand, N., Falck, J., Lukas, C., Syljuâ sen, R. G., Welcker, M., Bartek, J. and Lukas, J. (2000). Rapid destruction of human Cdc25A in response to DNA damage. Science 288, 1425-1429.
33. Malumbres, M. and Barbacid, M. (2009). Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 9, 153-166.
34. Manke, I. A., Nguyen, A., Lim, D., Stewart, M. Q., Elia, A. E. and Yaffe, M. B. (2005). MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol. Cell 17, 37-48.
35. Mecham, J. O., Rowitch, D., Wallace, C. D., Stern, P. H. and Hoffman, R. M. (1983). The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem. Biophys. Res. Commun. 117, 429-434.
36. Meyskens, F. L., Jr. andGerner, E.W. (1999).Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Clin. Can. Res. 5, 945-951.
37. Neshat, M. S., Raitano, A. B., Wang, H. G., Reed, J. C. and Sawyers, C. L. (2000). The survival function of the Bcr-Abl oncogene is mediated by Baddependent and -independent pathways: roles for phosphatidylinositol 3-kinase and Raf. Mol. Cell. Biol. 20, 1179-1186.
38. Pardee, A. B. (1974). A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. USA 71, 1286-1290.
39. Poirson-Bichat, F., Gonfalone, G., Bras-Gonçalves, R. A., Dutrillaux, B. and Poupon, M. F. (1997). Growth of methionine-dependent human prostate cancer (PC-3) is inhibited by ethionine combined with methionine starvation. Br. J. Cancer 75, 1605-1612.
40. Reichard, J. F., Schnekenburger, M. and Puga, A. (2007). Long term low-dose arsenic exposure induces loss of DNA methylation. Biochem. Biophys. Res. Commun. 352, 188-192.
41. Reinhardt, H. C. and Yaffe, M. B. (2009). Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr. Opin. Cell Biol. 21, 245-255.
42. Reinhardt, H. C., Aslanian, A. S., Lees, J. A. and Yaffe, M. B. (2007). p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 11, 175-189.
43. Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L. and Sabatini, D. M. (2008). The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496-1501.
44. Seidenfeld, J., Block, A. L., Komar, K. A. and Naujokas, M. F. (1986). Altered cell cycle phase distributions in cultured human carcinoma cells partially depleted of polyamines by treatment with difluoromethylornithine. Cancer Res. 46, 47-53.
45. Sengupta, T. K., Leclerc, G. M., Hsieh-Kinser, T. T., Leclerc, G. J., Singh, I. and Barredo, J. C. (2007). Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy. Mol. Cancer 6, 46.
46. Shackelford, D. B. and Shaw, R. J. (2009). The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat. Rev. Cancer 9, 563-575.
47. Shin, K. J., Wall, E. A., Zavzavadjian, J. R., Santat, L. A., Liu, J., Hwang, J. I., Rebres, R., Roach, T., Seaman, W., Simon, M. I. et al. (2006). A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc. Natl. Acad. Sci. USA 103, 13759-13764.
48. Stern, P. H., Wallace, C. D. and Hoffman, R. M. (1984). Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J. Cell. Physiol. 119, 29-34.
49. Su, N. Y., Flick, K. and Kaiser, P. (2005). The F-box protein Met30 is required for multiple steps in the budding yeast cell cycle. Mol. Cell. Biol. 25, 3875-3885.
50. Tisdale, M. J., Jack, G. W. and Eridani, S. (1983). Differential sensitivity of normal and leukaemic haemopoietic cells to methionine deprivation by Lmethioninase. Leuk. Res. 7, 269-277.
51. Tseng, C. H. (2008). Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan. Atherosclerosis 199, 12-18.
52. Wallick, C. J., Gamper, I., Thorne, M., Feith, D. J., Takasaki, K. Y., Wilson, S. M., Seki, J. A., Pegg, A. E., Byus, C. V. and Bachmann, A. S. (2005). Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitorinduced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells. Oncogene 24, 5606-5618.
53. Wang, W., Kramer, P. M., Yang, S., Pereira, M. A. and Tao, L. (2001). Reversedphase high-performance liquid chromatography procedure for the simultaneous determination of S-adenosyl-L-methionine and S-adenosyl-L-homocysteine in mouse liver and the effect of methionine on their concentrations. J. Chromatogr. B Biomed. Sci. Appl. 762, 59-65.
54. Winzen, R., Kracht, M., Ritter, B., Wilhelm, A., Chen, C. Y., Shyu, A. B., Müller, M., Gaestel, M., Resch, K. and Holtmann, H. (1999). The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinaseactivated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18, 4969-4980.
55. Zhuang, Y. and Miskimins, W. K. (2008). Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1. J. Mol. Signal. 3, 18.